TTK Healthcare Reports Q1 Results for FY2026; Reveals Strategic Asset Sale Agreement with Wipro
TTK Healthcare Limited has announced its unaudited financial results for the First Quarter ended June 30, 2026. The company reported key figures across various segments and provided updates regarding significant operational developments, including a major asset sale agreement.The Board of Directors approved the results in a meeting held on August 06, 2026.
Financial Highlights for Q1 FY2026
TTK Healthcare recorded total income from operations at Rs. 25,755.76 lakhs for the quarter ended June 30, 2026. The company's Total Income (including other income) stood at Rs. 27,435.23 lakhs for the quarter.The results show a consistent trend across reporting periods:
- Total Income from Operations: Rs. 25,755.76 lakhs (Q1 FY2026); Rs. 21,798.47 lakhs (Q1 FY2025 Audited); Rs. 22,642.98 lakhs (Q1 FY2025 Unaudited).
- Net Profit before Tax: The company reported a Net Profit of Rs. 2,885.83 lakhs for the quarter ended June 30, 2026, compared to Rs. 1,765.35 lakhs in the comparable period during FY 2024-25.
- Net Profit after Tax: The Net Profit after Tax stood at Rs. 2,127.92 lakhs for the quarter.
- Total Comprehensive Income: For the period, the Total Comprehensive Income was reported at Rs. 2,463.15 lakhs.
A snapshot of the financial performance indicators is detailed in the table below:
| Financial Metric | Q1 ended June 30, 2026 (Unaudited) | Q1 ended March 31, 2026 (Audited) | Q1 ended June 30, 2025 (Unaudited) |
|---|---|---|---|
| Total Income from Operations | 25,755.76 lakhs | 21,798.47 lakhs | 22,642.98 lakhs |
| Net Profit before Tax | 2,885.83 lakhs | 2,602.13 lakhs | 1,765.35 lakhs |
| Total Comprehensive Income | 2,463.15 lakhs | 1,958.73 lakhs | 1,357.13 lakhs |
Segment Performance Overview
The company's business is segmented into several divisions, including Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The segment-wise results reflect the operating profitability of these divisions.Total Net Sales/Income from Operations stood at 25,755.76 lakhs for the quarter.
Segment performance metrics are summarized in the following table:
| Segment | Q1 Ended June 30, 2026 (Net Profit before Tax) | Q1 Ended March 31, 2026 (Net Profit before Tax) |
|---|---|---|
| Protective Devices | 2,885.83 lakhs | 1,765.35 lakhs |
| Medical Devices | 758.02 lakhs | 349.26 lakhs |
| Consumer Products | 284.44 lakhs | 528.78 lakhs |
| Foods | 412.32 lakhs | 329.24 lakhs |
| Animal Welfare | 1,15.13 lakhs | 245.56 lakhs |
| Others | 10.84 lakhs | 8.91 lakhs |
Key Operational Updates and Events
TTK Healthcare provided details on several material operational events during the reporting periods:Major Strategic Agreement: The company entered into a definitive agreement with M/s. Wipro Enterprises Private Limited on July 23, 2026. This deal concerns the sale of EVA and Good Home Brands along with related assets for a consideration of Rs. 256 crores plus applicable GST. The net book value of the relevant assets as of June 30, 2026, was reported at Rs. 70.48 lakhs. This transaction is scheduled to be completed by September 30, 2026.
Protective Devices Write-off: During the Fourth Quarter of FY 2024-25, the company wrote off the entire value of Male Contraceptives pertaining to the Protective Devices Division. This write-off amounted to Rs. 586.39 lakhs and was due to a pause on foreign development assistance and subsequent cancellation of Purchase Orders related to the USAID Program.
Q1 USAID Transaction: In the First Quarter of the current financial year, the company received orders for inventory totaling Rs. 94.63 lakhs that were written off in FY 2024-25. Of an order worth Rs. 544.63 lakhs, TTK Healthcare invoiced inventory amounting to Rs. 509.92 lakhs at a selling value of Rs. 701.85 lakhs to USAID, which was included in the quarter's revenue.
Past Financial Events:
- The company recognized Rs. 350.42 lakhs as exceptional income during the previous financial year due to GST refund relating to earlier periods.
- A net charge of Rs. 757.87 lakhs was recognized in the previous financial year arising from the incremental impact assessed following changes in the definition of wages resulting from India's notification of four Labour Codes on November 21, 2025. This impact comprised Gratuity amounting to Rs. 823.02 lakhs and Long-term Compensated Absences of Rs. 284.85 lakhs, against which a provision of Rs. 350 lakhs created in FY 2020-21 was adjusted.
- Tax refund relating to AY 2016-17 & AY 2017-18 received following assessment completion was reported as tax related to earlier years in the previous year's results.
The company confirmed that it has no Subsidiary, Associate, or Joint Venture Company as of June 30, 2026.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.